Scalable Public Health Empowerment, Research, and Education Sites (SPHERES)
Launched by EIJKMAN OXFORD CLINICAL RESEARCH UNIT, INDONESIA · Aug 9, 2025
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called SPHERES, is looking at ways to improve health care in Indonesia, especially for pregnant women, newborn babies, and people with illnesses like tuberculosis, hepatitis B, high blood pressure, and diabetes. The goal is to help local health leaders use information and data more effectively to make better decisions that improve health services for these groups. Instead of testing a new medicine, this study focuses on improving how health care is delivered in local clinics and health offices.
People who live in the areas served by participating health centers and who use these health services may be part of this study, along with health care workers and district health officials who agree to take part. If you or your family members receive care from these facilities, you could be eligible. Participants won’t be undergoing medical treatments but will be involved in sharing information to help health leaders understand what’s working and what can be improved. The study is not yet recruiting participants, but it aims to make health care better for many people in the community by supporting smarter decisions based on real data.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Residing in or participating in the district catchment areas
- • Receiving services from participating health care facilities
- • Health providers and district health officials consent to participate in data collection
- Exclusion Criteria:
- • Individuals (health workers or patients) who decline to provide informed consent.
- • Individuals who are not directly involved in or accessing services from health care facilities or district health offices.
- • Inability to provide consent due to cognitive impairment or acute illness for health workers or district health officials involved in data collection
About Eijkman Oxford Clinical Research Unit, Indonesia
The Eijkman Oxford Clinical Research Unit (EOCRU) in Indonesia is a leading research institution dedicated to advancing clinical research in infectious diseases and public health. A collaboration between the Eijkman Institute for Molecular Biology and the University of Oxford, EOCRU focuses on conducting high-quality clinical trials that address pressing health challenges in Indonesia and the Southeast Asian region. With a commitment to ethical research practices and community engagement, EOCRU leverages cutting-edge scientific methodologies and a multidisciplinary approach to contribute valuable insights into disease prevention, treatment, and management, ultimately enhancing health outcomes in diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Purbalingga, Central Java, Indonesia
Gerung, West Nusa Tenggara, Indonesia
Patients applied
Trial Officials
Anuraj H Shankar, D. Sc.
Principal Investigator
Oxford University Clinical Research Unit Indonesia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported